Physician profile
David C Kerbl
NPI 1265969422
$6,406.43
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $885 · 2021: $2,156 · 2022: $2,169 · 2023: $836 · 2024: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $997.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,287.72 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $976.41 | 2020-2024 | |
| Boston Scientific Corporation | $939.08 | 2021-2023 | |
| Abiomed | $674.39 | 2022-2023 | Impella |
| Janssen Pharmaceuticals, INC | $349.04 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $293.34 | 2020-2022 | |
| Chiesi USA, INC. | $234.01 | 2020-2021 | |
| Astellas Pharma US INC | $99.99 | 2021 | |
| Merck Sharp & Dohme LLC | $79.62 | 2021-2022 | |
| Philips North America LLC | $75.04 | 2020-2024 | (Ck4) Mcot |
| Esperion Therapeutics, INC. | $54.98 | 2022 | |
| Amgen INC. | $52.01 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $37.60 | 2023 | Onpattro |
| Asahi Intecc USA, INC. | $37.04 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $31.02 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $28.54 | 2023 | Definity |
| Radius Health, INC. | $27.07 | 2019 | |
| Angiodynamics, INC. | $23.53 | 2022 | |
| Pfizer INC. | $20.59 | 2021 | |
| Medtronic, INC. | $20.32 | 2021 | |
| Vyera Pharmaceuticals, LLC | $18.75 | 2019 | |
| Cvrx, INC. | $16.58 | 2023 | Barostim Neo System |
| Medtronic Vascular, INC. | $16.46 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kerbl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.